Form D · Biotechnology
First Light Biosciences Inc.
Bedford, MA · CIK 0001652991
Offering snapshot reported Aug 6, 2018 · SEC filing
- Reported sold
- $3M Offering amount: $5.9M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 30, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2018 | Initial | $3,000,000 | No comparison | 2 | SEC filing |
| Jan 24, 2017 | Amendment | $1,792,895 | $981,720vs Aug 3, 2016 | 37 | SEC filing |
| Aug 3, 2016 | Initial | $811,175 | No comparison | 21 | SEC filing |
| Sep 14, 2015 | Initial | $2,868,055 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-318518
Source: Form D, filed Aug 6, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Arnold | Director |
| Thierry Bernard | Director |
| Richard Ganz | Director |
| Michael Lytton | Director |
| William Moffitt | Director |
| Tripp Peake | Director |
| Salvatore Salamone | Director |
| David Shapiro | Director |
| Donald Straus | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Oak Park Drive, 2 Nd Floor
Bedford, MA, 01730
Bedford, MA, 01730